Roxwood Medical Announces FDA 510(k) Clearance and US Commercial Launch of Its CenterCross Catheter

Submitted by kBLASTER Team on

by Business Wire

REDWOOD CITY, Calif.--()--Roxwood Medical Inc. announced today FDA 510(k) clearance for the US commercialization of its CenterCross Catheter for use in the coronary and peripheral vasculature. The CenterCross Catheter expands Roxwood Medical’s product offerings that already includes the FDA-cleared MultiCross Catheter platform for helping clinicians tackle blockages in their patients’ arteries.

See the full article here.

Go to kBLASTER for FDA 510(k) predicate search with effective result management to build your successful 510(k) clearance strategy.